🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of stereotactic b...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2014-04-08
Trial ID
NCT01918644
This open-label, multicenter, randomized phase II study will evaluate the u...
Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Start Date
2019-03-19
Trial ID
NCT03769103
Treatments Being Tested
The purpose of this study is to determine if the use of exploratory immunol...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2013-07-05
Trial ID
NCT01899989
Treatments Being Tested
This is a phase I, multicenter, open-label study starting with a dose explo...
Status
Active Not Recruiting
Location
Institut Bergonié
Start Date
2023-12-12
Trial ID
NCT05821231
Treatments Being Tested
Prostate Stereotactic ablative body radiotherapy (SABR) is an established t...
Status
Recruiting
Location
Sunnybrook Health Sciences Centre
Start Date
2024-03-01
Trial ID
NCT05600400
Treatments Being Tested
The purpose of this clinical trial is to determine whether using chemothera...
Status
Recruiting
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2023-09-21
Trial ID
NCT05679674
Treatments Being Tested
This single arm trial will investigate a novel way to plan and deliver SABR...
Status
Active Not Recruiting
Location
Medical University of South Carolina Hollings Cancer Center
Start Date
2023-05-12
Trial ID
NCT05668351
Treatments Being Tested
The researchers are doing this study to find out if stereotactic body radia...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Start Date
2021-12-09
Trial ID
NCT05169970
Treatments Being Tested
Background: Fewer than 10 percent of people with pancreas cancer can have ...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2021-06-15
Trial ID
NCT04327986
The primary objective of this phase 1 trial is to determine the dose-depend...
Status
Withdrawn
Location
Henry Ford Health System
Start Date
2017-01-13
Trial ID
NCT03029871
Treatments Being Tested